Max Rosett
Director of Finance/CFO at IMMUNOME, INC.
Net worth: 283 147 $ as of 29/04/2024
Profile
Max Rosett is currently working as the CFO, Chief Accounting Officer & EVP-Operations at Immunome, Inc. He previously worked as the Chief Operating Officer at MorphImmune, Inc. from 2022 to 2023 and as a Principal at Research Bridge Partners from 2018 to 2023.
Mr. Rosett graduated from the Georgia Institute of Technology in 2016 with a graduate degree and from Yale University in 2012 with an undergraduate degree.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
IMMUNOME, INC.
0.03% | 30/01/2024 | 19,856 ( 0.03% ) | 283 147 $ | 29/04/2024 |
Max Rosett active positions
Companies | Position | Start |
---|---|---|
IMMUNOME, INC. | Director of Finance/CFO | 01/01/2024 |
Former positions of Max Rosett
Companies | Position | End |
---|---|---|
Research Bridge Partners /Venture Capital/
Research Bridge Partners /Venture Capital/ Investment ManagersFinance Research Bridge Partners (Research Bridge Partners) is a venture capital firm founded in 2016 by Reid Hoffman. The firm is headquartered in Austin, Texas. | Corporate Officer/Principal | 31/10/2023 |
MorphImmune, Inc.
MorphImmune, Inc. BiotechnologyHealth Technology MorphImmune, Inc. is a biotechnology company that specializes in developing targeted oncology therapeutics. MorphImmune is based in West Lafayette, IN and has been led by CEO Clay B. Siegall since 2023. The company's proprietary targeted effector platform delivers payloads to diseased cells, reducing toxicity and increasing efficacy of known effector molecules. The company was founded on the research of Philip S. Low, Ph.D., the Presidential Scholar for Drug Discovery and Ralph C. Corley Distinguished Professor of Chemistry at Purdue University. | Chief Operating Officer | 30/09/2023 |
Training of Max Rosett
Yale University | Undergraduate Degree |
Georgia Institute of Technology | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
IMMUNOME, INC. | Health Technology |
Private companies | 2 |
---|---|
MorphImmune, Inc.
MorphImmune, Inc. BiotechnologyHealth Technology MorphImmune, Inc. is a biotechnology company that specializes in developing targeted oncology therapeutics. MorphImmune is based in West Lafayette, IN and has been led by CEO Clay B. Siegall since 2023. The company's proprietary targeted effector platform delivers payloads to diseased cells, reducing toxicity and increasing efficacy of known effector molecules. The company was founded on the research of Philip S. Low, Ph.D., the Presidential Scholar for Drug Discovery and Ralph C. Corley Distinguished Professor of Chemistry at Purdue University. | Health Technology |
Research Bridge Partners /Venture Capital/
Research Bridge Partners /Venture Capital/ Investment ManagersFinance Research Bridge Partners (Research Bridge Partners) is a venture capital firm founded in 2016 by Reid Hoffman. The firm is headquartered in Austin, Texas. | Finance |
- Stock Market
- Insiders
- Max Rosett